(Q40281819)

English

The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer

scientific article published on October 2006

In more languages
default values for all languages
No label defined

No description defined

Statements

The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer (English)
Darlene B Royce
Renee Risingsong
Charlotte R Williams
Michael B Sporn

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit